СПЕЦИАЛИЗИРАНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ ПО ДЕТСКИ БОЛЕСТИ ПРОФ ИВАН МИТЕВ ЕАД
A Bulgaria buyer, with 11 published contracts, most recently 4 months ago.
Top 5 suppliers won 98% of awarded value — £22.3m of £22.6m across 11 awards.
This contract involves the supply of the medication Guanfacine, which is listed under Article 266a, paragraph 2 of the Law on Medicinal Products in Human Medicine. The procurement follows the guidelines set forth in Regulation No. 10 dated November 17, 2011, by the Ministry of Health. The total valu
This contract involves the delivery of the medicinal product Calcium Folinate, which is not authorized for use in Bulgaria. The procurement is conducted in accordance with Regulation No. 10/17.11.2011 of the Ministry of Health. The total value of the contract is €12,148.30. The buyer is the Speciali
This contract involves the supply of a pharmaceutical product with the International Nonproprietary Name (INN) Entecavir. The product is listed under Article 266a, paragraph 2 of the Bulgarian Law on Medicinal Products. The total value of the contract is €40,742.55. The buyer is the Specialized Hosp
This contract involves the supply of the pharmaceutical product Sepiapterin, which is listed under Article 266a, paragraph 2 of the Bulgarian Law on Medicinal Products in Human Medicine. The contract is valued at approximately €371,962.17 and is intended for the Specialized Hospital for Active Treat
This contract involves the supply of a pharmaceutical product with the International Nonproprietary Name (INN) Burosumab, at a concentration of 30 mg/ml. This product is included in the list under Article 266a, paragraph 2 of the Bulgarian Law on Medicinal Products. The contract is published on the
This contract involves the supply of a pharmaceutical product with the International Nonproprietary Name (INN) Nitisinone at a concentration of 4 mg/ml. This product is included in the list under Article 266a, paragraph 2 of the Bulgarian Law on Medicinal Products. The buyer is the Specialized Hospi
This contract involves the supply of a pharmaceutical product containing Maralixibat chloride at a concentration of 9.5 mg/ml. This product is listed under Article 266a, paragraph 2 of the Bulgarian Law on Medicinal Products. The contract is valued at 2,943,000 EUR and is intended for use in the hea
This contract involves the supply of a pharmaceutical product with the International Nonproprietary Name (INN) 'Electrolytes', which includes various salts in combination. The product is listed under Article 266a, paragraph 2 of the Bulgarian Law on Medicinal Products in Human Medicine. The total va
This contract involves the supply of the pharmaceutical product Odevixibat, with an active ingredient of 1200 micrograms. The product is listed under Article 266a, paragraph 2 of the Bulgarian Law on Medicinal Products. The buyer is the Specialized Hospital for Active Treatment of Children's Disease
This contract involves the supply of a pharmaceutical product with the International Nonproprietary Name (INN) Olipudase alfa, at a dosage of 20 mg. This product is listed under Article 266a, paragraph 2 of the Bulgarian Law on Medicinal Products. The contract is published by the Specialized Hospita
